tiprankstipranks
Advertisement
Advertisement

Aligos Therapeutics announces inducement grants under Nasdaq listing rule

Aligos Therapeutics (ALGS) announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 26,000 shares of the Company’s stock to newly hired employees on June 10, 2025 in connection with the commencement of employment. The Inducement Grants were granted pursuant to Aligos’ 2024 Inducement Plan as an inducement material to these individuals entering employment in accordance with Nasdaq Listing Rule 5635(c)(4). The Plan is used exclusively for the grant of equity awards to individuals who were not previously employed by Aligos.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1